BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Convertible Debt (2017 - 2021)

Updated

Analysis

BioRestorative Therapies (BRTX) Convertible Debt (2017 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 250,000.00
Dec 31, 2020 1.28 Mn
Mar 31, 2020 1.07 Mn
Dec 31, 2019 920,000.00
Sep 30, 2019 2.78 Mn
Mar 31, 2019 743,142.00
Jun 30, 2017 25,000.00
Mar 31, 2017 100,000.00
API Access

BioRestorative Therapies Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=BRTX&period=max&api_key=YOUR_API_KEY